Orally Active Central Dopamine and Serotonin Receptor Ligands: 5-, 6-, 7-, and 8-[[(Trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the Formation of Active Metabolites in Vivo

Clas Sonesson, Maria Boije, Kjell Svensson, Agneta Ekman, Arvid Carlsson, Arthur G. Romero, Iain J. Martin, J. Neil Duncan, Laurence J. King, Håkan Wikström

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

The racemic triflate derivatives 5–8 of the 5-, 6-, 7-, and 8-hydroxylated 2-(di-n-propylamino)-tetralins 1–4 were shown to possess similar pharmacological profiles to their phenolic counterparts in in vitro binding and in vivo biochemical and behavioral assays in rats. Consequently, subcutaneous administration of the 5-, 6-, and 7-triflates displayed essentially dopaminergic agonist properties, while the 8-triflate was shown to be a selective 5-HT1A receptor agonist. With respect to their agonist activities, the triflates were less potent than their phenolic analogs. The absolute oral bioavailability of compound 8 (8-triflate) was 4–5 times greater than the corresponding hydroxylated compound. Interestingly, in the in vivo biochemical assay compound 8 was found to be more potent after oral than after subcutaneous administration, indicating formation of one or more active metabolites. Following a study of the metabolism of compound 8 in rat hepatocytes, the monopropyl analog 9 was identified as the major metabolite and was suprisingly found to be more potent than compound 8. Oral administration of compound 5 (5-triflate) resulted in behavioral and biochemical effects indicative of mixed DA/5-HT1A agonist properties not seen after subcutaneous administration. These results may also be indicative of the formation of active metabolites.

Original languageEnglish
Pages (from-to)3409-3416
Number of pages8
JournalJournal of Medicinal Chemistry
Volume36
Issue number22
DOIs
StatePublished - 1993

Fingerprint

Dive into the research topics of 'Orally Active Central Dopamine and Serotonin Receptor Ligands: 5-, 6-, 7-, and 8-[[(Trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the Formation of Active Metabolites in Vivo'. Together they form a unique fingerprint.

Cite this